Citadel Advisors’s Achaogen Inc AKAO Stock Holding History

Citadel Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,200	Closed	-$8K	–	10328
2019 Q1	$8K	Sell	17,200 -3,300	-16%	-$3.46K	﹤0.01%	9165
2018 Q4	$25K	Sell	20,500 -114,200	-85%	-$305K	﹤0.01%	8683
2018 Q3	$537K	Sell	134,700 -86,900	-39%	-$525K	﹤0.01%	6582
2018 Q2	$1.92M	Buy	221,600 +116,900	+112%	+$1.42M	﹤0.01%	4177
2018 Q1	$1.36M	Buy	104,700 +74,900	+251%	+$850K	﹤0.01%	4332
2017 Q4	$320K	Buy	+29,800	New	+$374K	﹤0.01%	6359
2017 Q2	–	Sell	-28,700	Closed	-$724K	–	8396
2017 Q1	$724K	Buy	+28,700	New	+$590K	﹤0.01%	4466

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors's AKAO Position: Q2 2019 in Review

Citadel Advisors sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 40,659 shares — an estimated $18K sold.

Citadel Advisors first reported a position in AKAO in Q1 2015 and held it in 10 quarters. The position peaked at $18.8M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

Citadel Advisors reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
Citadel Advisors sold 40,659 Achaogen Inc shares in Q2 2019, an estimated $18K.
Citadel Advisors first reported a position in Achaogen Inc in Q1 2015 and held it in 10 quarters.
Citadel Advisors's Achaogen Inc position peaked at $18.8M in Q2 2017.
8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.